𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulatory effects in man of nortriptyline, a tricyclic antidepressant drug

✍ Scribed by Freyschuss, U. ;Sj�qvist, F. ;Tuck, D. ;Asberg, M.

Publisher
Springer-Verlag
Year
1970
Weight
446 KB
Volume
2
Category
Article
ISSN
0369-9498

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of the tricyclic antidepressa
The effect of the tricyclic antidepressant drug, nortriptyline on left ventricular ejection fraction and left ventricular volumes
✍ O. J. Hartling; J. Marving; P. Knudsen; A. Dahl; P. F. Høilund-Carlsen; L. Hartl 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 293 KB

Eight patients with major depression but otherwise healthy underwent radionuclide cardiography before and during nortriptyline treatment. The second examination was performed when the nortriptyline plasma concentration was within the therapeutic range (60-150 micrograms X l-1). Heart rate, arterial

13C and 1H NMR studies of nitrogen inver
13C and 1H NMR studies of nitrogen inversion and molecular flexibility in the tricyclic antidepressant drug trimipramine maleate
✍ Jennifer C. Wilson; Sharon L. A. Munro; David J. Craik 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

The solution conformations and dynamics of the antidepressant drug trimipramine maleate were investigated by 'H and I3C NMR spectroscopy. Of particular interest was an observed non-equivalence of the N-methyl groups in the aliphatic sidechain of the drug, which is present in both 'H and I3C spectra

A comparison of side effects of selectiv
A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis
✍ Kenneth Wilson; Pat Mottram 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract ## Objective To examine the relative tolerability and side effect profile of tricyclic antidepressants and selective serotonin reuptake inhibitors in older depressed people. ## Methods A systematic literature search generated 37 randomised controlled trials of TCAs and SSRIs of which